Followers | 7 |
Posts | 5499 |
Boards Moderated | 0 |
Alias Born | 09/11/2013 |
Tuesday, April 16, 2019 1:30:01 PM
1) The US FDA acknowledged receipt of NNVC's Pre-IND briefing documents.
2) NNVC acknowledged the US FDA's acknowledgement of receipt of NNVC's Pre-IND briefing documents.
3) The US FDA personnel who received NNVC's Pre-IND briefing documents took a one hour lunch at the Bistro Francais on Waverly Ave. Thursday afternoon to discuss NNVC's Pre-IND briefings during the appetizer timeframe of the lunch.
4) NNVC is waiting for the response from the US FDA regarding April 16, 2019 submission to the US FDA of NNVC's Pre-IND briefing documents and receipt by US FDA of same.
5) NNVC founder, Dr. Anil Diwan, expresses confusion as to why the past several informative PRs regarding NNVC's Pre_IND briefing documents submission have had little to no effect on the NNVC share price.
6) NNVC received acknowledgement from the US FDA that an IND meeting has been scheduled on June 37th, 2019 at 1:83 pm Greenwich Mean Time
7) NNVC attended the IND meeting with the US FDA on June 37th, 2019 at 1:83 pm Greenwich Mean Time and are confident the US FDA will respond in some fashion. Whether that response is favorable or not is beyond NNVC's control.
8) The US FDA requested NNVC test materials but nobody was manning the phones at NNVC and missed the call. When the FDA calls back, NNVC will be sure to submit the requested test materials in a timely fashion not to exceed the amount of time it takes NNVC founder Dr. Anil Diwan to transfer all NNVC remaining funds to Theracour.
Just because you can doesn't mean you should.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM